ELAVL1 and breast cancer: Specifically, DHTS interacts with HuR, stabilizing it in a locked conformation, hindering competitive RNA binding, and inhibiting the migration of breast cancer, cervical adenocarcinoma, and colon carcinoma cells [195,196].